Effects of Serine Protease Inhibitor and Prostaglandin I2 on Liver Transplantation From Non-Heart-Beating Rat Donors

Transplantation Proceedings

Volumn 40, Issue 7, 2008, Pages 2152-2155

  Miyagi, S ^a   Okada, A ^a   Oikawa, K ^a   Sato, A ^a   Fujimori, K ^a   Satomi, S ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; NAFAMSTAT MESILATE; PROSTACYCLIN; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; LIVER PRESERVATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ANIMALS; BILE; EPOPROSTENOL; GRAFT SURVIVAL; LIVER CIRCULATION; LIVER TRANSPLANTATION; MALE; PORTAL VEIN; RATS; RATS, WISTAR; SERINE PROTEINASE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51249100671     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.06.010     Document Type: Article

References (4)

1. Melemdz H.V., and Heaton N.D. Understanding "marginal" liver grafts. Transplantation 68 4 (1999) 469
2. Tsukamoto S., Ohkohchi N., Fukumori T., et al. Elimination of Kupffer cells and nafamostat mesilate rinse prevent reperfusion injury in liver grafts from agonal non-heart-beating donors. Transplantation 67 11 (1999) 1396
3. Kawazoe Y., Eguchi S., Sugiyama N., et al. Protective effect of nafamostat mesilate on injury of porcine hepatocytes by human plasma. Cell Transplant 8 4 (1999) 419
4. Satoh M., Ohkohchi N., Tsukamoto S., et al. Successful liver transplantation from agonal non-heart-beating donors in pigs. Transplant Int 16 (2003) 100